Published in Virology on March 01, 1976
Formation and structure of infectious DNA of spleen necrosis virus. J Virol (1977) 3.29
Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. Proc Natl Acad Sci U S A (1984) 2.24
Infectious murine leukemia virus from DNA of virus-negative AKR mouse embryo cells. Proc Natl Acad Sci U S A (1978) 1.37
Complexity and polyadenylic acid content of visna virus 60-70S RNA. J Virol (1977) 1.13
Assay of noninfectious fragments of DNA of avian leukosis virus-infected cells by marker rescue. J Virol (1977) 1.09
In vitro synthesis of infectious transforming DNA by the avian sarcoma virus reverse transcriptase. J Virol (1979) 1.08
Absence of circularly permuted and largely redundant sequences in the genome of visna virus. J Virol (1978) 0.88
Infectious primate type C virus proviral DNA in productively infected cells. J Virol (1978) 0.75
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Pathogenesis of lentivirus infections. Nature (1986) 4.61
An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol (1966) 3.72
Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol (1981) 3.46
A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol (1981) 3.27
The slow infection caused by visna virus. Curr Top Microbiol Immunol (1975) 2.99
Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med (1976) 2.96
Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83
Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol (1994) 2.67
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis (1995) 2.63
A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol (1974) 2.60
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47
Visna DNA synthesis and the tempo of infection in vitro. Virology (1982) 2.47
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med (1974) 2.35
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med (1980) 2.14
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A (1997) 2.11
Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Gene expression in visna virus infection in sheep. Nature (1981) 1.98
Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol (2000) 1.92
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Antigenic variation in visna virus. Cell (1979) 1.81
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A (1993) 1.79
Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines. Infect Immun (1980) 1.77
Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med (1972) 1.73
Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol (1996) 1.60
A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis (2000) 1.51
Visna virus DNA: discovery of a novel gapped structure. Virology (1981) 1.51
Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis (1990) 1.49
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Visna virus RNA synthesis. J Virol (1977) 1.48
Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Natl Acad Sci U S A (1991) 1.45
Measles virus nucleotide sequences: detection by hybridization in situ. Science (1981) 1.45
Interleukin 2 receptor expression in unstimulated murine splenic T cells. Localization to L3T4+ cells and regulation by non-H-2-linked genes. J Exp Med (1986) 1.44
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol (1999) 1.43
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol (1976) 1.42
Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest (1985) 1.41
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology (1985) 1.27
Determination of influenzavirus neuraminidase inhibition titres. Bull World Health Organ (1975) 1.27
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Isolation of replication-competent molecular clones of visna virus. Virology (1991) 1.26
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA (1981) 1.24
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs. J Clin Invest (1972) 1.23
Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol (2008) 1.22
A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med (1986) 1.22
Serological definition of the lentivirus group of retroviruses. J Virol (1979) 1.20
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest (1999) 1.19
Demonstration of a DNA provirus in the lytic growth of visna virus. Nat New Biol (1973) 1.18
A comparison of the high molecular weight RNAs of visna virus and Rous sarcoma virus. Virology (1974) 1.18
Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology (1985) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
Frequency of variant antigens in Giardia lamblia. Exp Parasitol (1990) 1.16
Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1985) 1.14
Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS. J Infect Dis (1997) 1.13
Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol (1996) 1.12
Inhibition of RNA slow viruses by thiosemicarbazones. Biochem Biophys Res Commun (1973) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology (1992) 1.08
Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr (1996) 1.07
Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med (1977) 1.07
Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med (1994) 1.07
Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. Am J Med (1981) 1.05
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med (1995) 1.04
Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad Sci U S A (1996) 1.04
The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. Microb Pathog (1987) 1.04
Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol (1979) 1.02
The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent. J Immunol (1972) 1.01
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses (2000) 1.00
Quantitative analysis of visna virus replication in vivo. Virology (1985) 1.00
Evaluation of daily meatal care with poly-antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J Urol (1983) 0.99
Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol (1998) 0.98
Increased expression of heat shock protein, transferrin, and beta 2-microglobulin in astrocytes during scrapie. Microb Pathog (1993) 0.97
Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice. Antimicrob Agents Chemother (1981) 0.97
Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts. J Intern Med (2009) 0.97